ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,388,000 | -63.0% | 54,000 | -62.5% | 0.79% | +24.6% |
| Q2 2021 | $3,756,000 | -42.5% | 144,000 | -22.2% | 0.63% | -47.9% |
| Q1 2021 | $6,536,000 | +24.0% | 185,142 | -11.3% | 1.21% | +96.4% |
| Q4 2020 | $5,270,000 | -23.6% | 208,798 | +14.1% | 0.62% | -48.4% |
| Q3 2020 | $6,901,000 | -31.4% | 183,000 | -22.2% | 1.20% | -54.5% |
| Q2 2020 | $10,067,000 | +1539.6% | 235,098 | +643.8% | 2.63% | +1711.0% |
| Q1 2020 | $614,000 | -32.1% | 31,608 | -9.2% | 0.14% | -30.0% |
| Q4 2019 | $904,000 | -69.1% | 34,811 | -67.6% | 0.21% | -62.2% |
| Q3 2019 | $2,928,000 | -59.0% | 107,441 | -59.6% | 0.55% | -38.4% |
| Q2 2019 | $7,149,000 | -49.6% | 266,269 | -45.7% | 0.89% | -56.6% |
| Q1 2019 | $14,179,000 | -18.9% | 490,438 | -24.5% | 2.05% | -43.7% |
| Q4 2018 | $17,494,000 | – | 649,607 | – | 3.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |